Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Celgene Corporation published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 17
» View ky3.com items only
    Jun 12, 2013 |Story| Reuters
  1. Wall St. slides as worry lingers over future of stimulus

    NEW YORK (Reuters) - U.S. stocks fell on Wednesday, with the Dow sliding more than 100 points on another volatile day as traders extended a selloff driven by concern about central banks winding down their stimulus measures.
    Reuters
    NEW YORK (Reuters) - U.S. stocks fell on Wednesday, with the Dow sliding more than 100 points on another volatile day as traders extended a selloff driven by concern about central banks winding down their stimulus measures. The S&P 500 was caught between...

    Tags: Kentucky Fried Chicken, Prices, Computing and Information Technology Industry, American Express Company, Citigroup Incorporated

  2. Jun 11, 2013 |Story| Reuters
  3. Celgene arthritis drug maintains efficacy at 52 weeks-study

    Reuters
    By Bill Berkrot June 11 (Reuters) - Celgene Corp's experimental drug for psoriatic arthritis maintained its ability to significantly reduce painful symptoms through 52 weeks of treatment, according to data from a late stage study being presented this...

    Tags: Biotechnology Industry, Placebo, Medical Research, Skin Conditions, Humira (drug)

  4. Jun 10, 2013 |Story| Reuters
  5. Agios Pharmaceuticals files for IPO of up to $86 mln

    Reuters
    June 10 (Reuters) - Biopharmaceutical company Agios Pharmaceuticals Inc filed with U.S. regulators on Monday to raise up to $86 million in an initial public offering of common stock. The Cambridge, Massachusetts-based company told the U.S. Securities and...

    Tags: Financing and Stock Offerings, U.S. Securities and Exchange Commission, Physiology, Drugs and Medicines, Goldman Sachs Group, Inc.

  6. May 31, 2013 |Story| Reuters
  7. EU backs Celgene, Aegerion drugs; sees no Lantus cancer risk

    Reuters
    LONDON, May 31 (Reuters) - European regulators have recommended approval of a new drug from Celgene for patients with multiple myeloma whose disease has worsened after being treated with other cancer drugs. Friday's green light from the European...

    Tags: Drugs and Medicines, Lantus (drug)

  8. May 31, 2013 |Story| Reuters
  9. U.S. RESEARCH ROUNDUP: Blackrock, CME Group, Morgan Stanley, Splunk

    Reuters
    May 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Blackrock and CME Group, on Friday. HIGHLIGHTS * U.S. Asset Managers: JP Morgan raises target on Blackrock, others * CME...

    Tags: CIT Group Incorporated, American Express Company, Myriad Genetics Incorporated, Petroleum Industry, Blackrock Inc

  10. May 28, 2013 |Story| Reuters
  11. FACTBOX-U.S. biotech shares outpace broader stock market

    Reuters
    May 28 (Reuters) - Shares of biotechnology companies have outrun a bull market for U.S. stocks, rising nearly 50 percent over the past 12 months as investors look for new growth stories. Investors' enthusiasm, despite the inherent risk of drug...

    Tags: Biotechnology Industry, Amgen Inc., New Products, Prices, Cystic Fibrosis

  12. May 28, 2013 |Story| Reuters
  13. ANALYSIS-Biotech's bull run starts to look frothy

    Reuters
    By Deena Beasley May 28 (Reuters) - Biotech stocks are so hot that even some of the bulls are starting to find themselves on edge. An index of biotech drugmakers' shares has climbed nearly 50 percent in the past 12 months to all-time highs as the...

    Tags: Gilead Sciences Inc., Rentals, Biotechnology Industry, Earnings, Amgen Inc.

  14. Feb 3, 2013 |Story| Los Angeles Times
  15. MemorialCare Health System buys headquarters in Costa Mesa

    Nonprofit medical provider MemorialCare Health System will move its headquarters from Fountain Valley to Costa Mesa because it has acquired a 15-acre corporate campus near the 405 Freeway.
    Nonprofit medical provider MemorialCare Health System will move its headquarters from Fountain Valley to Costa Mesa because it has acquired a 15-acre corporate campus near the 405 Freeway. MemorialCare will consolidate several teams now in other Southern...

    Tags: General Practitioners, Health and Medical Professionals, Realty, Health Insurance

  16. Oct 3, 2012 |Story| Reuters
  17. L.A.'s richest man ups the ante for city, cancer fight

    LOS ANGELES (Reuters) - As owner of 5 percent of the Los Angeles Lakers, Patrick Soon-Shiong could walk into the locker room of the storied basketball franchise any time for a chat with stars like Kobe Bryant. But the richest man in Los Angeles chooses to sit with the rest of his team's fans.
    Reuters
    LOS ANGELES (Reuters) - As owner of 5 percent of the Los Angeles Lakers, Patrick Soon-Shiong could walk into the locker room of the storied basketball franchise any time for a chat with stars like Kobe Bryant. But the richest man in Los Angeles chooses to...

    Tags: Healthy Diet, Medical Research, Philip Anschutz, Verizon Communications, Diabetes

  18. Nov 4, 2011 |Story| WGN-AM
  19. Myeloma Today

    Please join The Leukemia & Lymphoma Society for a patient program on myeloma on Wednesday, November 16th from 6 p.m. - 8 p.m.
    Staff reporter
    Please join The Leukemia & Lymphoma Society for a patient program on myeloma on Wednesday, November 16th from 6 p.m. - 8 p.m. Dr. John Maciejewski, MD, PhD from Rush University Cancer Center will cover topics thatinclude an overview of Myeloma, such as...

    Tags: Chicago, Hospitals and Clinics, Millennium Pharmaceuticals Incorporated, Rush University Medical Center, Drugs and Medicines

  20. Jul 23, 2006 |Story| Tribune Media Services
  21. Dec 23, 2007 |Story| Tribune Media Services
 1  2Next >
Original site for Celgene Corporation topic gallery.